Sample Collection and Tracking for the Developmental Therapeutics Clinic
Launched by NATIONAL CANCER INSTITUTE (NCI) · Aug 31, 2017
Trial Information
Current as of May 15, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focusing on improving how researchers understand cancer treatment by collecting and linking data from patients. If you join the Developmental Therapeutics Clinic (DTC), you will be asked to allow researchers to access your past and current medical records, as well as any research samples you have provided. This will help them see how different treatments have worked over time for patients with various types of cancer, including neoplasms and lymphoma.
To participate, you need to be at least 18 years old and currently being evaluated or treated for cancer at the DTC. You'll not need to provide any new samples for this study. Instead, the goal is to combine information from all the studies you’ve been part of, which will help improve future cancer therapies. This trial is currently recruiting participants, and there are no specific exclusions based on health conditions, so if you meet the age and treatment criteria, you could be eligible.
Gender
ALL
Eligibility criteria
- * INCLUSION CRITERIA:
- • Patients who are being evaluated and/or treated for cancer or benign tuumors in the Developmental Therapeutics Clinic at the NIH Clinical Center
- • Ability to understand and willingness to sign a written informed consent document indicating their willingness to have data from their tissue or biologic fluid research specimens and limited medial information used for research as outlined in this protocol and to allow protocol staff access to the CRIS database and their Medical Records Number (MRN).
- • Age greater than or equal to 18 years
- ECLUSION CRITERIA:
- • None
About National Cancer Institute (Nci)
The National Cancer Institute (NCI) is a prominent component of the National Institutes of Health (NIH), dedicated to advancing cancer research and improving patient outcomes through innovative clinical trials. As a leading sponsor of cancer-related studies, NCI focuses on facilitating the development of new therapies, enhancing prevention strategies, and understanding the biology of cancer. The institute collaborates with academic institutions, healthcare providers, and industry partners to conduct rigorous clinical trials that aim to translate scientific discoveries into effective treatments. NCI’s commitment to fostering a robust research environment supports the mission to eliminate cancer as a major health problem.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Patients applied
Trial Officials
Alice P Chen, M.D.
Principal Investigator
National Cancer Institute (NCI)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials